A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Tagworks Pharmaceuticals BV
Alterome Therapeutics, Inc.
SillaJen, Inc.
Nuvectis Pharma, Inc.
Boehringer Ingelheim
Boehringer Ingelheim
Pheon Therapeutics
Akamis Bio
Adaptimmune
Sichuan Baili Pharmaceutical Co., Ltd.
Nuvectis Pharma, Inc.
Akamis Bio
Akamis Bio
Kiromic BioPharma Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Keystone Nano, Inc
Advaxis, Inc.
Kyowa Kirin Co., Ltd.
Pfizer
R-Pharm
Celon Pharma SA
Myeloid Therapeutics
Celgene
Multitude Therapeutics Inc.
Cantargia AB
Blueprint Medicines Corporation
Synermore Biologics Co., Ltd.
Takeda
Amgen
Genocea Biosciences, Inc.
Akamis Bio
Andes Biotechnologies
Akamis Bio
Celgene
Telios Pharma, Inc.
Polaris Group
Pfizer
TaiRx, Inc.
GlaxoSmithKline
BioNumerik Pharmaceuticals, Inc.
AstraZeneca
Merck Sharp & Dohme LLC
Sun Pharma Advanced Research Company Limited
Dynavax Technologies Corporation
Evolve Biologics
TaiRx, Inc.
Eisai Inc.
Seagen Inc.